Cargando…
p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways
BACKGROUND AND AIMS: siRNAs represent an encouraging novel alternative in cancer therapy as a result of targeting the mutated tumour suppressor genes or activated oncogenes. Targeting oncogenic signals, as the mutated p53 gene that gains oncogenic role, we observed inhibition of migration, a downreg...
Autores principales: | BRAICU, OVIDIU, PILECZKI, VALENTINA, BRAICU, CORNELIA, ACHIMAS-CADARIU, PATRICIU, IRIMIE, ALEXANDRU, BERINDAN-NEAGOE, IOANA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632892/ https://www.ncbi.nlm.nih.gov/pubmed/26609266 http://dx.doi.org/10.15386/cjmed-434 |
Ejemplares similares
-
Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model
por: Braicu, Cornelia, et al.
Publicado: (2015) -
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2012) -
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
por: Braicu, Ovidiu-Leonard, et al.
Publicado: (2017) -
Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
por: Pileczki, Valentina, et al.
Publicado: (2016) -
Aberrant miRNAs expressed in HER-2 negative breast cancers patient
por: Braicu, Cornelia, et al.
Publicado: (2018)